Literature DB >> 18410477

Familiality of major depressive disorder and gender differences in comorbidity.

M Verhagen1, A van der Meij, B Franke, W Vollebergh, R de Graaf, J Buitelaar, J G Janzing.   

Abstract

OBJECTIVE: Gender differences exist in the prevalence and psychiatric comorbidity of major depressive disorder (MDD). This study investigates whether familiality of MDD contributes to observed gender differences in comorbidity.
METHOD: Familial (f-MDD) and non-familial (nf-MDD) MDD cases from a population sample were assessed for comorbid dysthymia, anxiety disorders and alcohol-related disorders using the Composite International Diagnostic Interview (CIDI). Logistic regression analyses were performed to examine the effect of f-MDD on gender differences in comorbidity, adjusted for confounders.
RESULTS: Women with f-MDD reported significantly more comorbid dysthymia and generalized anxiety disorder (GAD) than their male counterparts; women with nf-MDD reported significantly more comorbid simple phobias and agoraphobia than their male counterparts. Gender differences in comorbid panic disorder and alcohol-related disorders occurred independently of the familial load. Adjustment for age of onset, severity and recurrence of MDD did not change these results.
CONCLUSION: Models to explain comorbidity patterns of MDD differ by gender. Familiality of MDD should be taken into account.

Entities:  

Mesh:

Year:  2008        PMID: 18410477     DOI: 10.1111/j.1600-0447.2008.01186.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Familiality of major depressive disorder and patterns of lifetime comorbidity. The NEMESIS and GenMood studies. A comparison of three samples.

Authors:  Maaike Verhagen; Annemarie van der Meij; Barbara Franke; Wilma A M Vollebergh; Ron de Graaf; Jan K Buitelaar; Joost G E Janzing
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

2.  Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

Authors:  Antonella Benvenuti; Paola Rucci; Simona Calugi; Giovanni B Cassano; Mario Miniati; Ellen Frank
Journal:  Int Clin Psychopharmacol       Date:  2010-03       Impact factor: 1.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.